Short report: Serologic evidence of human ehrlichiosis in Peru

Pedro L. Moro, Jyotsna Shah, Olga Li, Robert H Gilman, Nick Harris, Manuel H. Moro

Research output: Contribution to journalArticle

Abstract

A serosurvey for human ehrlichiosis caused by Ehrlichia chaffeensis and Anaplasma phagocytophilum was performed in different regions of Peru by using indirect immunofluorescence assays (IFAs). Regions included an urban community in a shantytown in Lima (Pampas) and three rural communities located on the northern coast of Peru (Cura Mori), in the southern Peruvian Andes (Cochapata), and in the Peruvian jungle region (Santo Tomas). An overall E. chaffeensis seroprevalence of 13% (21 of 160) was found by IFA. Seroprevalences in females and males was 15% (16 of 106) and 9% (5 of 53), respectively. Seroprevalences in Cura Mori, Cochapata, Pampas, and Santo Tomas were 25% (10 of 40), 23% (9 of 40), 3% (1 of 40), and 3% (1 of 40), respectively. Seroprevalences in Cura Mori and Cochapata were significantly higher than in Santo Tomas or Pampas (P <0.01). No sera were reactive to A. phagocytophilum. These findings suggest that human infection with E. chaffeensis occurs in Peru. Further studies are needed to characterize Ehrlichia species in Peru, their vectors and their clinical significance.

Original languageEnglish (US)
Pages (from-to)242-244
Number of pages3
JournalAmerican Journal of Tropical Medicine and Hygiene
Volume80
Issue number2
StatePublished - Feb 2009

Fingerprint

Ehrlichiosis
Peru
Ehrlichia chaffeensis
Seroepidemiologic Studies
Anaplasma phagocytophilum
Morus
Ehrlichia
Rural Population
Indirect Fluorescent Antibody Technique
Fluorescent Antibody Technique
Infection
Serum

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases
  • Virology
  • Medicine(all)

Cite this

Moro, P. L., Shah, J., Li, O., Gilman, R. H., Harris, N., & Moro, M. H. (2009). Short report: Serologic evidence of human ehrlichiosis in Peru. American Journal of Tropical Medicine and Hygiene, 80(2), 242-244.

Short report : Serologic evidence of human ehrlichiosis in Peru. / Moro, Pedro L.; Shah, Jyotsna; Li, Olga; Gilman, Robert H; Harris, Nick; Moro, Manuel H.

In: American Journal of Tropical Medicine and Hygiene, Vol. 80, No. 2, 02.2009, p. 242-244.

Research output: Contribution to journalArticle

Moro, PL, Shah, J, Li, O, Gilman, RH, Harris, N & Moro, MH 2009, 'Short report: Serologic evidence of human ehrlichiosis in Peru', American Journal of Tropical Medicine and Hygiene, vol. 80, no. 2, pp. 242-244.
Moro, Pedro L. ; Shah, Jyotsna ; Li, Olga ; Gilman, Robert H ; Harris, Nick ; Moro, Manuel H. / Short report : Serologic evidence of human ehrlichiosis in Peru. In: American Journal of Tropical Medicine and Hygiene. 2009 ; Vol. 80, No. 2. pp. 242-244.
@article{0478b2d365a543409e1127329ad5339b,
title = "Short report: Serologic evidence of human ehrlichiosis in Peru",
abstract = "A serosurvey for human ehrlichiosis caused by Ehrlichia chaffeensis and Anaplasma phagocytophilum was performed in different regions of Peru by using indirect immunofluorescence assays (IFAs). Regions included an urban community in a shantytown in Lima (Pampas) and three rural communities located on the northern coast of Peru (Cura Mori), in the southern Peruvian Andes (Cochapata), and in the Peruvian jungle region (Santo Tomas). An overall E. chaffeensis seroprevalence of 13{\%} (21 of 160) was found by IFA. Seroprevalences in females and males was 15{\%} (16 of 106) and 9{\%} (5 of 53), respectively. Seroprevalences in Cura Mori, Cochapata, Pampas, and Santo Tomas were 25{\%} (10 of 40), 23{\%} (9 of 40), 3{\%} (1 of 40), and 3{\%} (1 of 40), respectively. Seroprevalences in Cura Mori and Cochapata were significantly higher than in Santo Tomas or Pampas (P <0.01). No sera were reactive to A. phagocytophilum. These findings suggest that human infection with E. chaffeensis occurs in Peru. Further studies are needed to characterize Ehrlichia species in Peru, their vectors and their clinical significance.",
author = "Moro, {Pedro L.} and Jyotsna Shah and Olga Li and Gilman, {Robert H} and Nick Harris and Moro, {Manuel H.}",
year = "2009",
month = "2",
language = "English (US)",
volume = "80",
pages = "242--244",
journal = "American Journal of Tropical Medicine and Hygiene",
issn = "0002-9637",
publisher = "American Society of Tropical Medicine and Hygiene",
number = "2",

}

TY - JOUR

T1 - Short report

T2 - Serologic evidence of human ehrlichiosis in Peru

AU - Moro, Pedro L.

AU - Shah, Jyotsna

AU - Li, Olga

AU - Gilman, Robert H

AU - Harris, Nick

AU - Moro, Manuel H.

PY - 2009/2

Y1 - 2009/2

N2 - A serosurvey for human ehrlichiosis caused by Ehrlichia chaffeensis and Anaplasma phagocytophilum was performed in different regions of Peru by using indirect immunofluorescence assays (IFAs). Regions included an urban community in a shantytown in Lima (Pampas) and three rural communities located on the northern coast of Peru (Cura Mori), in the southern Peruvian Andes (Cochapata), and in the Peruvian jungle region (Santo Tomas). An overall E. chaffeensis seroprevalence of 13% (21 of 160) was found by IFA. Seroprevalences in females and males was 15% (16 of 106) and 9% (5 of 53), respectively. Seroprevalences in Cura Mori, Cochapata, Pampas, and Santo Tomas were 25% (10 of 40), 23% (9 of 40), 3% (1 of 40), and 3% (1 of 40), respectively. Seroprevalences in Cura Mori and Cochapata were significantly higher than in Santo Tomas or Pampas (P <0.01). No sera were reactive to A. phagocytophilum. These findings suggest that human infection with E. chaffeensis occurs in Peru. Further studies are needed to characterize Ehrlichia species in Peru, their vectors and their clinical significance.

AB - A serosurvey for human ehrlichiosis caused by Ehrlichia chaffeensis and Anaplasma phagocytophilum was performed in different regions of Peru by using indirect immunofluorescence assays (IFAs). Regions included an urban community in a shantytown in Lima (Pampas) and three rural communities located on the northern coast of Peru (Cura Mori), in the southern Peruvian Andes (Cochapata), and in the Peruvian jungle region (Santo Tomas). An overall E. chaffeensis seroprevalence of 13% (21 of 160) was found by IFA. Seroprevalences in females and males was 15% (16 of 106) and 9% (5 of 53), respectively. Seroprevalences in Cura Mori, Cochapata, Pampas, and Santo Tomas were 25% (10 of 40), 23% (9 of 40), 3% (1 of 40), and 3% (1 of 40), respectively. Seroprevalences in Cura Mori and Cochapata were significantly higher than in Santo Tomas or Pampas (P <0.01). No sera were reactive to A. phagocytophilum. These findings suggest that human infection with E. chaffeensis occurs in Peru. Further studies are needed to characterize Ehrlichia species in Peru, their vectors and their clinical significance.

UR - http://www.scopus.com/inward/record.url?scp=59649096094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59649096094&partnerID=8YFLogxK

M3 - Article

C2 - 19190221

AN - SCOPUS:59649096094

VL - 80

SP - 242

EP - 244

JO - American Journal of Tropical Medicine and Hygiene

JF - American Journal of Tropical Medicine and Hygiene

SN - 0002-9637

IS - 2

ER -